ReviewCurrent treatment options in oncology2023

Anti-HER2 Drugs for the Treatment of Advanced HER2 Positive Breast Cancer.

Malwina Stanowicka-Grada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.